Promotion of Vaginal Health With CH2 Vaginal Gel After Pelvic Radiotherapy

This is a prospective clinical trial planning to enroll female patients who have completed pelvic radiotherapy. Participants will undergo a 12-week intervention with either CH2 vaginal gel or vaginal rehabilitation exercises. The primary endpoint is the change in the Female Sexual Function Index scores.

NCT Number	NCT06997887
Lead Sponsor	National Taiwan University Hospital
Conditions	Gynecologic Malignancy
Enrollment	60 participants
Start Date	2025-05-09
Primary Completion	2028-05-09 (estimated)
Study Completion	2030-05-09 (estimated)
Updated on ClinicalTrials.gov	2025-06-27